Cargando…
Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective
Mitochondrial diseases (MDs) are a group of severe genetic disorders caused by mutations in the nuclear or mitochondrial genome encoding proteins involved in the oxidative phosphorylation (OXPHOS) system. MDs have a wide range of symptoms, ranging from organ-specific to multisystemic dysfunctions, w...
Autores principales: | Di Donfrancesco, Alessia, Massaro, Giulia, Di Meo, Ivano, Tiranti, Valeria, Bottani, Emanuela, Brunetti, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231068/ https://www.ncbi.nlm.nih.gov/pubmed/35745859 http://dx.doi.org/10.3390/pharmaceutics14061287 |
Ejemplares similares
-
Mitochondrial Transplantation in Mitochondrial Medicine: Current Challenges and Future Perspectives
por: D’Amato, Marco, et al.
Publicado: (2023) -
Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies
por: Bottani, Emanuela, et al.
Publicado: (2020) -
Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches
por: Di Meo, Ivano, et al.
Publicado: (2015) -
Exploiting hiPSCs in Leber's Hereditary Optic Neuropathy (LHON): Present Achievements and Future Perspectives
por: Peron, Camille, et al.
Publicado: (2021) -
PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients
por: Di Donfrancesco, Alessia, et al.
Publicado: (2023)